Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-09

FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a diclofenac sodium and misoprostol product under an Original Application for BluePoint Laboratories, signaling a generic clearance for this combin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac sodium and misoprostol (diclofenac sodium and misoprostol)

Snippet

ORIG AP for DICLOFENAC SODIUM AND MISOPROSTOL (DICLOFENAC SODIUM AND MISOPROSTOL)